• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

INSM:US

17.0900 USD 0.4200 2.40%

As of 17:20:00 ET on 07/31/2014.

Snapshot for Insmed Inc (INSM)

Open: 17.3100 Day's Range: 16.7400 - 17.5980 Volume: 367,018
Previous Close: 17.5100 52wk Range: 10.1600 - 22.2900 1-Yr Rtn: +54.52%

Stock Chart for INSM

No chart data available.
  • INSM:US 17.1300
  • 1D
  • 1M
  • 1Y
17.5100
Interactive INSM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INSM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.5100
Est. EPS (USD) (12/2014) -1.7700
Est. PEG Ratio -
Market Cap (M USD) 671.17
Shares Outstanding (M) 39.27
30 Day Average Volume 1,166,660
Price/Book (mrq) 5.0942
Price/Sale (ttm) 47.1892
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INSM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for INSM

Insmed, Inc. is a biopharmaceutical company focused on developing and commercializing novel, targeted inhaled therapies for patients with high unmet need battling serious orphan lung diseases.

William H Lewis "Will"President/CEOAndrew T DrechslerChief Financial Officer
Matthew PaulsChief Commercial OfficerChristine A PellizzariSecretary/General Counsel
More Company Profile & Key Executives for INSM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil